Multi-species RNA interference technology for root knot nematode control
This innovative RNA interference (RNAi) technology provides targeted control of multiple Root Knot Nematode species with high efficacy and minimal off-target effects. It involves low-dose, exogenously applied dsRNA for sustainable agricultural protection.
Overview
Root Knot Nematodes (RKN) pose a significant threat to agriculture, and current control options are limited. This RNA interference (RNAi) technology offers a targeted, sustainable solution by using exogenously applied double-stranded RNA (dsRNA) to effectively control various RKN species. The technology requires minimal amounts of dsRNA for high nematode lethality, ensuring cost-effectiveness and environmental sustainability. Its application has been demonstrated on plants, showing promise for real-world agricultural protection.
Technical specifications
Key features:
- Exogenous RNAi application effectively targets multiple essential genes in RKNs, achieving high lethality with low dsRNA doses.
- Custom software designs dsRNA for multi-species targeting with minimized off-target effects.
- Delivery platforms include seed treatment and foliar application, ensuring effective dsRNA movement to root tissues.
- Preliminary results suggest successful delivery in early and later plant growth stages.
Technology readiness level
Current development is at TRL 4, with laboratory validation of components and potential delivery methods. Future validation includes expanding on plant delivery systems and conducting genome sequencing for broader nematode targeting, aiming to progress towards field trials.
About The University of Queensland
The University of Queensland is a large, multi-campus public research university in Brisbane with a comprehensive academic and research profile. Industry partners engage through hospital-embedded laboratories and clinical sites, pilot testbeds, and field campuses across Queensland that enable prototyping, trials, and validation in real-world settings. Co-location with major health precincts and proximity to Brisbane’s innovation districts make collaboration and talent access straightforward, while on-campus incubation and professional education support workforce upskilling. Research is supported by competitive national funding from the Australian Research Council and the National Health and Medical Research Council, alongside state and industry investment. A dedicated technology transfer office and commercialization company manage IP, licensing, sponsored research agreements, and spin-out formation.
delivered to your inbox.